Maria S. Zharkova
Moscow, MOW 119435, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Tryptophan Metabolites in the Progression of Liver Diseases.
Journal: Biomolecules
Published: September 28, 2024
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis.
Journal: World journal of hepatology
Published: January 14, 2024
Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study.
Journal: Journal of clinical medicine
Published: January 02, 2024
Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis.
Journal: International journal of molecular sciences
Published: December 28, 2023
Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis.
Journal: Microorganisms
Published: August 11, 2023
Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis.
Journal: Metabolites
Published: June 21, 2023
The Role of Bile Acids in the Human Body and in the Development of Diseases.
Journal: Molecules (Basel, Switzerland)
Published: April 14, 2022
Efficacy and safety of COVID-19 vaccination in patients with cirrhosis.
Journal: World journal of hepatology
Published: February 23, 2022
Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial.
Journal: World journal of hepatology
Published: February 15, 2022
A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling.
Journal: Molecules (Basel, Switzerland)
Published: December 24, 2021
Gut dysbiosis and body composition in cirrhosis.
Journal: World journal of hepatology
Published: May 16, 2021
Last Updated: 09/26/2026